Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration

1 Mar 2013

Abstract excerpt

Age-related macular degeneration (AMD) is the leading cause of blindness in people over age 55 in the U.S. and the developed world. This condition leads to the progressive impairment of central visual acuity. There are significant limitations in the understanding of disease progression in AMD as well as a lack of effective methods of treatment. Lately, there has been considerable enthusiasm for application of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23452406
DOI: 10.1186/1479-5876-11-53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degenerationPMID 23452406Read ↗

Cellular models and therapies for age-related macular degenerationSemantic proximity Read ↗

AMD and Stem Cell-Based TherapiesSemantic proximity Read ↗

Stem cell based therapies for age-related macular degeneration: The promises and the challengesSemantic proximity Read ↗

Embryonic stem cells as a treatment for macular degenerationSemantic proximity Read ↗

Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases.Semantic proximity Read ↗

Stem cells as tools for studying the genetics of inherited retinal degenerations.Semantic proximity Read ↗

Stem Cell Therapy for Retinal Degeneration: The Evidence to DateSemantic proximity Read ↗

Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosaSemantic proximity Read ↗

Establishing a human cell-based model system for macular degenerationSemantic proximity Read ↗

Pluripotent stem cell therapy for retinal diseasesSemantic proximity Read ↗

A Systematic Review; Efficacy Assessment of Novel Therapy in Treating Age-related Macular DegenerationSemantic proximity Read ↗

Choice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.